Sustainable product manufacturer Med-X (MXRX.US) files for direct listing on Nasdaq

According to Golden Ten Data, sustainable product manufacturer Med-X filed documents with the U.S. Securities and Exchange Commission (SEC) last Friday to register its stock and complete a direct listing on the Nasdaq. The company plans to list on Nasdaq under the ticker symbol "MXRX." As this direct listing does not involve an underwriting commitment, there are no underwriters for the transaction; Maxim Group will act as financial advisor.

The Med-X shares for this listing will be sold by existing shareholders, and the company will not raise new funds through this listing. Registered shareholders may sell up to 13.1 million ordinary shares, which is equivalent to all issued shares of the company.

Med-X develops and sells natural "green" products through its Nature-Cide, Thermal-Aid, and Malibu Brands divisions. Nature-Cide produces minimum-risk, plant-based pesticides and repellents for the professional pest control, hospitality, agriculture, and other industries; Thermal-Aid manufactures natural hot and cold pain relief products. Both types of products are sold through national distributors and e-commerce platforms. For the six months ending June 2025, Nature-Cide accounted for approximately 54% of the company’s revenue, and Thermal-Aid for approximately 44%. Data shows the company’s revenue for the twelve months ending June 30, 2026 was $2 million.